Connie Matsui is of HALOZYME THERAPEUTICS, INC.. Currently has a direct ownership of 183,035 shares of HALO, which is worth approximately $8.6 Million. The most recent transaction as insider was on Nov 29, 2024, when has been sold 10,470 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 183K
5.41% 3M change
2.12% 12M change
Total Value Held $8.6 Million

CONNIE MATSUI Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 29 2024
SELL
Bona fide gift
-
10,470 Reduced 5.41%
183,035 Common Stock
Apr 25 2024
BUY
Grant, award, or other acquisition
-
6,501 Added 3.25%
193,505 Common Stock
May 05 2023
BUY
Grant, award, or other acquisition
-
8,065 Added 4.13%
187,004 Common Stock
Nov 16 2022
SELL
Bona fide gift
-
9,250 Reduced 4.92%
178,939 Common Stock
May 05 2022
BUY
Grant, award, or other acquisition
-
6,206 Added 3.19%
188,189 Restricted Stock Units
Nov 05 2021
SELL
Open market or private sale
$1,294,400 $40.45 p/Share
32,000 Reduced 14.95%
181,983 Common Stock
May 05 2021
BUY
Grant, award, or other acquisition
-
5,230 Added 2.39%
213,983 Restricted Stock Units

Also insider at

ARTLW
ARTELO BIOSCIENCES, INC. Industrials
STRO
SUTRO BIOPHARMA, INC. Healthcare
CM

Connie Matsui

San Diego, CA

Track Institutional and Insider Activities on HALO

Follow HALOZYME THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HALO shares.

Notify only if

Insider Trading

Get notified when an Halozyme Therapeutics, Inc. insider buys or sells HALO shares.

Notify only if

News

Receive news related to HALOZYME THERAPEUTICS, INC.

Track Activities on HALO